Caricamento...

Is it time for biomarker-based diagnostic criteria for prodromal Alzheimer's disease?

Drug candidates targeting amyloid-β (Aβ) pathology in Alzheimer's disease are in different phases of clinical trials. These treatments will probably be most effective in the earlier stages of the disease, before neurodegeneration is too severe, but at the same time symptoms are vague and the cl...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Blennow, Kaj, Zetterberg, Henrik
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2010
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2876786/
https://ncbi.nlm.nih.gov/pubmed/20441609
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/alzrt31
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !